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Introduction: Development of moderate-severe hospital-acquired anemia (HAA) during admission for AMI, defined as hemoglobin (Hgb) drop 
from normal to <11 g/dL during hospitalization, is associated with higher mortality and worse health status, and often occurs in the absence of 
recognized bleeding. Whether diagnostic blood loss from phlebotomy contributes to the development of HAA is unknown.
Methods:  We studied 17,676 AMI patients in the Cerner Health Facts database, stratified by presence or absence of moderate-severe HAA. Health 
Facts included the lab tests, as well as date and time of every blood draw. Patients’ total diagnostic blood loss was calculated by multiplying the 
number and types of blood tubes drawn by the standard blood volume for each tube type. Hierarchical modified Poisson regression was used to test 
the association between phlebotomy volume and the development of moderate-severe HAA, adjusting for hospital site, demographics, comorbidities, 
disease severity and treatment variables. Sensitivity analyses were conducted after excluding patients with documented bleeding and after stratifying 
by length of stay (LOS).
Results:  Moderate-severe HAA developed in 3,549 patients (20%). Total diagnostic blood loss ranged from 12ml to 1864ml, and mean 
phlebotomy volume was significantly higher in patients with (182±149 ml) than without HAA (86.2±55.9 ml, p<0.001). The risk of developing HAA 
was greater with increasing phlebotomy volume (per 50 ml: RR 1.17 (1.13-1.21), p<0.001). After multivariable adjustment, each 50 ml of blood 
drawn for laboratory tests was associated with a 14% increase in risk of HAA (RR 1.14 (1.11-1.17), p<0.001). Results were consistent in patients 
without documented bleeding (RR 1.14 (1.11-1.16) per 50 ml, p<0.001) and stratified by LOS (LOS ≤ 4 days: RR 1.30 (95% CI 1.15-1.46) per50 
ml; LOS ≥ 4 days RR 1.11 (95% CI 1.09-1.14) per 50 ml, p<0.001).
Conclusion: Blood loss from phlebotomy is independently associated with the development of moderate-severe HAA. These findings suggest 
that HAA may be preventable by implementing strategies to limit both the number of blood draws and the volume of blood removed for diagnostic 
testing.
